Molecular Insight Pharmaceuticals
Latest round
- Series C
Last raised
- Apr 2005
Total raised
- $35M
Investors
- 5
About Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals specializes in the development of novel radiopharmaceuticals for diagnosis and treatment in oncology. The company is headquartered in Cambridge, US.Molecular Insight Pharmaceuticals focuses on creating advanced diagnostic and therapeutic solutions for cancer care. Their key offerings include innovative radiopharmaceuticals designed for targeted imaging and treatment of various cancers. These products aim to enhance diagnostic accuracy and treatment efficacy for healthcare providers. They are focused on developing new radiopharmaceuticals aimed at improving cancer treatment efficacy, with releases anticipated in the next few years. Additionally, Molecular Insight Pharmaceuticals intends to explore expansion into international markets, particularly in Europe and Asia, by 2010, to increase access to their innovative solutions.
Who invested in Molecular Insight Pharmaceuticals
5 investors across 2 rounds
See all investors in Molecular Insight Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Molecular Insight Pharmaceuticals
Who invested in Molecular Insight Pharmaceuticals?
Molecular Insight Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Molecular Insight Pharmaceuticals raised?
Molecular Insight Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Molecular Insight Pharmaceuticals last raise money?
Molecular Insight Pharmaceuticals's most recent round on record is a Series C, in Apr 2005.
What does Molecular Insight Pharmaceuticals do?
Molecular Insight Pharmaceuticals specializes in the development of novel radiopharmaceuticals for diagnosis and treatment in oncology.
Where is Molecular Insight Pharmaceuticals headquartered?
Molecular Insight Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Molecular Insight Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Molecular Insight Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Molecular Insight Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.